"Alnylam Pharmaceuticals-Global Patient Safety and Risk Management Postdoctoral Research Fellow"

Alnylam Pharmaceuticals-Global Patient Safety and Risk Management Postdoctoral Research Fellow

About the Opportunity

Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry.

Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities.

In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Patient Safety and Risk Management fellowship, based in Cambridge, MA.

About Alnylam

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Responsibilities

Overview

Global Patient Safety and Risk Management (GPSRM) oversees all activities related to the detection, assessment, understanding, and prevention of adverse effects or other medicine-related safety concerns to ensure safe use of medicines and to safeguard health of patients. The fellow can expect to gain a thorough understanding of pharmacovigilance activities and actively participate in the development and maintenance of the drug safety profiles for our revolutionary RNAi platform.

Key Responsibilities:

• Provide scientific and strategic assistance to safety product leads to support Alnylam products
• Participate in the collection, interpretation, and presentation of safety data in internal forums
• Support signal detection and management activities with lead safety physicians and PV scientists
• Engage in safety data review, analysis, and reporting of safety data to internal and external stakeholders by planning, managing, and authoring safety aggregate reports (PBRERs, DSURs)
• Participate in the development and management of Risk Management Plans

Qualifications

• Doctor of Pharmacy degree from an ACPE-accredited institution
• Eligible for pharmacist licensure in the State of Massachusetts
• Excellent oral and written communication skills
• Strong time management and leadership abilities
• Ability to work independently and take initiative on a variety of projects at both the industry site and Northeastern

Additional Information

Applicants should submit the following application materials by the priority deadline of October 31, 2025:

1. Curriculum vitae (CV), uploaded
2. Unofficial PharmD transcripts, uploaded
3. Cover letter, uploaded

Three formal letters of recommendation (LORs) should be sent directly from the letter writer to PharmDFellowships@northeastern.edu by November 21, 2025. LOR writers must include the candidate's name and the fellowship program(s) in the subject line (e.g., Smith, John - Alnylam, GSK).

Address cover letter and letters of recommendation to:

J. Andrew Orr-Skirvin, PharmD, BCOP
Clinical Professor, Department of Pharmacy & Health Systems Sciences
Pharmaceutical Industry Fellowship Program Director
360 Huntington Ave, 140 The Fenway R218 Boston, MA 02115

Compensation Grade/Pay Type: 108S

Expected Hiring Range: $59,425.00 - $83,935.00